Evidence map›Paper›PMID 33255222›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis of 5'-Thiamine-Capped RNA.

Marvin Möhler, Katharina Höfer, Andres Jäschke

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marvin MöhlerInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany.
Katharina HöferInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany.ORCID 0000-0002-7472-9887
Andres JäschkeInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany.ORCID 0000-0002-4625-2655
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA 5'-modifications are known to extend the functional spectrum of ribonucleotides. In recent years, numerous non-canonical 5'-modifications, including adenosine-containing cofactors from the group of B vitamins, have been confirmed in all kingdoms of life. The structural component of thiamine adenosine triphosphate (thiamine-ATP), a vitamin B1 derivative found to accumulate in

Indexed as

Chemistry Techniques, SyntheticAdenosine TriphosphateBiotinylationCatalysisDNA-Directed RNA PolymerasesMolecular StructureRNARNA CapsThiamineThiamine TriphosphateViral Proteinsadenosine thiamine triphosphateAdenosine Triphosphatebacteriophage T7 RNA polymeraseDNA-Directed RNA PolymerasesRNARNA CapsThiamineThiamine TriphosphateViral Proteinschemical capture of thiamine-capped RNAclick chemistryin vitro transcriptionnon-canonical initiating nucleotide (NCIN)RNA modificationthiamine-adenosine diphosphatethiamine adenosine triphosphatethiamine-capped RNAthiamine (vitamin B1)

Identifiers

PMID33255222
PMCPMC7727699
OpenAlexW3107385089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.